Skip to main navigation
Skip to search
Skip to main content
University of Luebeck Home
English
Deutsch
Home
Research Units
Experts
Projects
Publications
Prizes
Spin-Offs
Media
Activities
Search by expertise, name or affiliation
Risk of infections in patients with pemphigus treated with rituximab vs. azathioprine or mycophenolate mofetil: a large-scale global cohort study
Khalaf Kridin
*
, Noor Mruwat, Kyle T. Amber,
Ralf J. Ludwig
*
Corresponding author for this work
Institute of Experimental Dermatology
Bar-Ilan University
Barch Padeh Medical Center,
Rush University
6
Citations (Scopus)
Overview
Fingerprint
Projects
(1)
Fingerprint
Dive into the research topics of 'Risk of infections in patients with pemphigus treated with rituximab vs. azathioprine or mycophenolate mofetil: a large-scale global cohort study'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Medicine & Life Sciences
Pemphigus
100%
Mycophenolic Acid
92%
Azathioprine
88%
Rituximab
86%
Cohort Studies
54%
Confidence Intervals
47%
Infections
37%
Cytomegalovirus Infections
21%
Osteomyelitis
21%
Parasitic Diseases
21%
Pneumonia
16%
Progressive Multifocal Leukoencephalopathy
13%
Pneumocystis carinii
13%
Pneumocystis Pneumonia
12%
Pneumococcal Vaccines
12%
Simplexvirus
10%
Propensity Score
10%
Cytomegalovirus
9%
Hepatitis B virus
9%
Antiviral Agents
8%
Tuberculosis
8%
Therapeutics
8%
Adrenal Cortex Hormones
8%
Virus Diseases
7%
Pharmaceutical Preparations
4%
Population
3%